ArticleNature chemistry2026
An alkyl-swap platform for late-stage modification of secondary N-methylamines.
Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The selective functionalization of unprotected amines with simple, unactivated alkenes and alkynes remains a challenge in contemporary synthesis. Here we present a strategy for the peripheral modification of secondary N-methylamines that complements state-of-the-art approaches and tolerates a wide range of functional groups and native amine substrates. This method is primed for application in late-stage functionalization contexts, including the direct bioconjugation of fully functionalized, unprotected building blocks and complex peptides. The retrosynthetic flexibility unlocked by this method also enables the preparation of several commercial, high-grossing pharmaceuticals in a single synthetic step.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.